diclofenac has been researched along with Nasopharyngeal Carcinoma in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1% diclofenac sodium for 1 month for his dry eye." | 7.78 | Late corneal perforation with topical diclofenac sodium use after radiotherapy. ( Demirel, S; Sarac, O, 2012) |
| "1% diclofenac sodium for 1 month for his dry eye." | 3.78 | Late corneal perforation with topical diclofenac sodium use after radiotherapy. ( Demirel, S; Sarac, O, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demirel, S | 1 |
| Sarac, O | 1 |
1 other study available for diclofenac and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Late corneal perforation with topical diclofenac sodium use after radiotherapy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma; Corneal Perforat | 2012 |